...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith cost basis
2
Aug 29, 2017 04:25PM

I'm not sure why you care.  If a day ever comes when we have shares to sell, the cost basis was set waaaaay back when Zen split from RVX.

2
Aug 30, 2017 11:28AM
1
Aug 30, 2017 11:47AM
2
Aug 30, 2017 12:56PM
3
Aug 30, 2017 04:49PM
Share
New Message
Please login to post a reply